Fredun Pharmaceuticals Limited (BOM:539730)
India flag India · Delayed Price · Currency is INR
1,577.60
+43.45 (2.83%)
At close: Mar 9, 2026

Fredun Pharmaceuticals Revenue

Fredun Pharmaceuticals had revenue of 1.61B INR in the quarter ending December 31, 2025, with 56.70% growth. This brings the company's revenue in the last twelve months to 5.91B, up 45.58% year-over-year. In the fiscal year ending March 31, 2025, Fredun Pharmaceuticals had annual revenue of 4.54B with 30.35% growth.

Revenue (ttm)
5.91B
Revenue Growth
+45.58%
P/S Ratio
1.26
Revenue / Employee
22.64M
Employees
261
Market Cap
7.45B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20254.54B1.06B30.35%
Mar 31, 20243.48B734.81M26.75%
Mar 31, 20232.75B502.16M22.37%
Mar 31, 20222.24B906.43M67.74%
Mar 31, 20211.34B211.22M18.74%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bharat Parenterals 3.50B
Anuh Pharma 7.68B
Wanbury 6.58B
Sudarshan Pharma Industries 6.44B
Kopran 6.20B
Venus Remedies 7.03B
Fermenta Biotech 5.44B
Kilitch Drugs (India) 2.07B
Revenue Rankings